Home › NDC Lookup › RxCUI directory › RxCUI 199521

Vigabatrin 500 MG Oral Tablet — RxCUI 199521

RxNorm drug concept · Semantic clinical drug
RxCUI 199521 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199521
Official nameVigabatrin 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)1,982 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vigabatrin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Vigabatrin is specifically for seizures that haven't responded well to other treatments. It's not a first choice — it's reserved for situations where other options haven't worked,...
  • Why is my doctor prescribing this instead of a more common seizure medication?
  • Yes, this is a real and serious risk that's important to understand. Vigabatrin can permanently narrow your field of vision — sometimes described as tunnel vision — and in some peo...
  • What's this I heard about vision loss? Should I be worried?
📖 Read our full Vigabatrin guide →

🕸️ Concept Web — How Vigabatrin 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vigabatrin 500 MG Oral Tablet RxCUI 199521

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vigabatrin 14851
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sabril 152332
    • Vigadrone 2047863
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vigabatrin Oral Tablet 374291
    • Vigabatrin Oral Product 1160520
    • Vigabatrin Pill 1160521
    • Vigabatrin Oral Tablet [Sabril] 860894
    • Vigabatrin Oral Tablet [Vigadrone] 2642352
    • Sabril Oral Product 1184194
    • Sabril Pill 1184195
    • Vigadrone Oral Product 2047866
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vigabatrin 500 MG SCDC · 333433
  • Vigabatrin Oral Tablet SCDF · 374291
  • Vigabatrin Oral Product SCDG · 1160520
  • Vigabatrin Pill SCDG · 1160521

Brand-Name Concepts

  • Vigabatrin 500 MG Oral Tablet [Sabril] SBD · 860895
  • Vigabatrin 500 MG Oral Tablet [Vigadrone] SBD · 2642353
  • Vigabatrin 500 MG [Sabril] SBDC · 860893
  • Vigabatrin 500 MG [Vigadrone] SBDC · 2047864
  • Vigabatrin Oral Tablet [Sabril] SBDF · 860894
  • Vigabatrin Oral Tablet [Vigadrone] SBDF · 2642352
  • Sabril Oral Product SBDG · 1184194
  • Sabril Pill SBDG · 1184195
  • Vigadrone Oral Product SBDG · 2047866
  • Vigadrone Pill SBDG · 2642351

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 199521 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0652-25 100 TABLET in 1 BOTTLE (0054-0652-25) Vigabatrin Hikma Pharmaceuticals USA Inc 2022-09-09
00245-6001-11 1 BOTTLE in 1 CARTON (0245-6001-11) / 100 TABLET in 1 BOTTL... VIGADRONE Upsher-Smith Laboratories, LLC 2023-06-30
00591-3851-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-3851-01) Vigabatrin Actavis Pharma, Inc. 2019-02-06
42799-0950-01 100 TABLET in 1 BOTTLE (42799-950-01) Vigabatrin Edenbridge Pharmaceuticals LLC. 2022-06-29
43598-0651-01 100 TABLET, FILM COATED in 1 BOTTLE (43598-651-01) Vigabatrin Dr. Reddys Laboratories Inc., 2021-02-01
59651-0367-01 1 BOTTLE in 1 CARTON (59651-367-01) / 100 TABLET in 1 BOTTL... Vigabatrin Aurobindo Pharma Limited 2022-05-10
67386-0111-01 100 TABLET, FILM COATED in 1 BOTTLE (67386-111-01) SABRIL Lundbeck Pharmaceuticals LLC 2009-08-21
69238-1424-01 100 TABLET in 1 BOTTLE (69238-1424-1) Vigabatrin Amneal Pharmaceuticals NY LLC 2022-06-27
70710-1287-01 100 TABLET, FILM COATED in 1 BOTTLE (70710-1287-1) vigabatrin Zydus Pharmaceuticals (USA) Inc. 2022-01-20
70771-1654-01 100 TABLET, FILM COATED in 1 BOTTLE (70771-1654-1) vigabatrin Zydus Lifesciences Limited 2022-01-20
80005-0167-11 1 BOTTLE in 1 CARTON (80005-167-11) / 100 TABLET, FILM COAT... vigabatrin Carnegie Pharmaceuticals LLC 2026-02-18
Observed labelers: Actavis Pharma, Inc. (1) · Amneal Pharmaceuticals NY LLC (1) · Aurobindo Pharma Limited (1) · Carnegie Pharmaceuticals LLC (1) · Dr. Reddys Laboratories Inc., (1) · Edenbridge Pharmaceuticals LLC. (1) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.